All In Biotech

Drug Trial Radar · NCT04759885

Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®

Efficacy and Safety of mAnniTol in Bowel Preparation: Assessment of Adequacy and Presence of Intestinal levelS of Hydrogen and Methane During Elective Colonoscopy aFter mAnnitol or Standard Split 2-liter Polyethylene Glycol Solution Plus asCorbaTe - a Phase II/III, International, Multicentre, Randomized, Parallel-group, endoscOpist-bliNded, Dose-finding/Non-inferiority Study - SATISFACTION

Last checked: Nov 20, 2026Latest source record: Dec 8, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 886 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

886

Actual

Start

Jun 18, 2020

Primary completion

Jul 16, 2021

Study completion Jul 16, 2021

Sponsor

Lead sponsor
NTC srlIndustry
Sponsor type
Industry
First posted
Feb 18, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this dose finding/comparative efficacy study is to first single out the most appropriate dose of mannitol for bowel preparation (phase II) and, subsequently, demonstrate the non-inferiority of the efficacy of single dose mannitol vs standard split 2L PEG ASC (Moviprep®) (phase III) in bowel preparation for colonoscopy .

Conditions

  • Elective Colonoscopy

Interventions

  • Phase II: NTC015 low doseDrug

    Participants should self administer the preparation within 30 minutes and drink clear liquid according to local practice at the centre to prevent dehydration

  • Phase II: NTC015 medium doseDrug

    Participants should self administer the preparation within 30 minutes and drink clear liquid according to local practice at the centre to prevent dehydration

  • Phase II: NTC015 high doseDrug

    Participants should self administer the preparation within 60 minutes and drink clear liquid according to local practice at the centre to prevent dehydration

  • Phase III: NTC015 selected doseDrug

    Participants should self administer the preparation within 30 minutes and drink clear liquid according to local practice at the centre to prevent dehydration

  • Phase III: Polyethylene glycol plus ascorbate solution (2L PEG ASC)Drug

    The instructions for product administration are followed according to the Summary of Product Characteristics. One treatment consists of two litres of Moviprep® taken according to split-dose regimen. The first litre of Moviprep® is prepared by dissolving one sachet A and one sachet B together in water to make one litre of solution. The reconstituted solution must be drunk over a period of one to two hours the evening before colonoscopy. About half a litre of clear liquid should be drunk in the next hour to prevent dehydration according to local practice at the centre. This process should be repeated with a second litre of Moviprep® prepared by dissolving one sachet A and one sachet B together in water to make one litre of solution in the early morning of the day of the procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase II - Dose Finding: Proportion of Patients With Adequate Bowel CleansingTime frame: During the colonoscopy procedure, carried out within 7 days of the screening visit, the evaluation is performed
  2. Phase III - Non-inferiority: Proportion of Patients With Adequate Bowel CleansingTime frame: During the colonoscopy procedure, carried out within 7 days of the screening visit, the evaluation is performed, at least 4 hours after end of intake, following product instruction as per protocol

Locations

35 sites in 4 countries. Site status is shown where the registry gives one.

  • Centre Hospitalier Henri Duffaut

    Avignon, France

  • Hospices civils de Lyon

    Lyon, France

  • Hôpital Edouard Herriot

    Lyon, France

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France

  • Klinikum der Stadt Ludwigshafen

    Ludwigshafen, Germany

  • Praxis für Gastroenterologie und Fachärztliche Innere Medizin, Im Haus der Gesundheit

    Ludwigshafen am Rhein, Germany

  • Katholisches Klinikum Mainz

    Mainz, Germany

  • Klinikum Worms Medizinische Klinik II

    Worms, Germany

  • Azienda Ospedaliero-Universitaria Maggiore della Carità

    Novara, Italy

  • ASST Sette Laghi - Ospedale di Circolo e Fondazione Macchi

    Varese, Italy

  • IRCCS "Saverio De Bellis"

    Castellana Grotte, BA, Italy

  • Fondazione Poliambulanza - Istituto Ospedaliero

    Brescia, BR, Italy

  • ASSL Carbonia - Presidio Ospedaliero CTO di Iglesias

    Iglesias, CI, Italy

  • Ospedale Valduce

    Como, CO, Italy

  • Fondazione Casa Sollievo Della Sofferenza

    San Giovanni Rotondo, FG, Italy

  • ASST Rhodense - Presidi di Rho e Garbagnate

    Garbagnate Milanese, MI, Italy

  • Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano

    Milan, MI, Italy

  • ASST Grande Ospedale Metropolitano Niguarda

    Milan, MI, Italy

  • IRCCS Ospedale San Raffaele

    Milan, MI, Italy

  • Istituto Europeo di Oncologia

    Milan, MI, Italy

  • IRCCS Policlinico San Donato

    San Donato Milanese, MI, Italy

  • Azienda USL di Modena - Ospedale Ramazzini di Carpi

    Carpi, MO, Italy

  • Azienda Ospedaliero Universitaria Pisana- Ospedale Cisanello

    Pisa, PI, Italy

  • Centro di Riferimento Oncologico IRCCS

    Aviano, PN, Italy

  • Policlinico Universitario A. Gemelli

    Roma, RO, Italy

  • Presidio Ospedaliero Santa Chiara

    Trento, TN, Italy

  • Ospedale Sacro Cuore

    Negrar, VR, Italy

  • Irkutsk State Medical Academy of Postgraduate Education

    Irkutsk, Russia

  • Clinical Hospital of Russian Railways N.A. Semashko

    Moscow, Russia

  • Moscow Clinical Research and Practical Center of the Department of Health

    Moscow, Russia

  • State Central Clinical Hospital A. N. Ryzhykh

    Moscow, Russia

  • Railway Clinical Hospital

    Rostov-on-Don, Russia

  • Private educational organization of higher education "Medical University "Reaviz"

    Samara, Russia

  • Medical Center of Diagnostics and Prevention

    Yaroslavl, Russia

  • Regional Oncological Clinical Hospital

    Yaroslavl, Russia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.